Athena Heart [310] Review

Stop other Class I or III antiarrhythmics (e.g., amiodarone, sotalol) before starting Multaq. Avoid strong (e.g., ketoconazole).

Monitor closely if the patient is also taking warfarin, as dronedarone can increase warfarin exposure. 4. Patient Monitoring ATHENA HEART [310]

: Contraindicated in patients with symptomatic heart failure or recent hospitalization for heart failure (NYHA Class IV or symptomatic Class II-III). Stop other Class I or III antiarrhythmics (e

Clinicians should monitor several factors to prevent adverse outcomes: as dronedarone can increase warfarin exposure.

Based on the code , this guide provides a breakdown of the ATHENA clinical trial (A Trial with dronedarone to prevent Hospitalization or death in patients with Atrial fibrillation) and the associated use of dronedarone (brand name Multaq ) for cardiovascular health. 1. Overview of the ATHENA Trial

The official FDA label outlines critical safety measures based on ATHENA data: :

: Conduct regular ECGs to monitor for potential proarrhythmic effects or excessive QT prolongation.